|
|
Opportunities in Stem Cell TechnologyPublished by: Kalorama Information Published: Feb. 1, 2002 - 408 Pages Special Offer. Now 25% off the original price of $3500.Table of Contents Foreword Objectives Target Audience Scope and Content of Report Methodology Chapter One: Introduction
What Exactly Is a Stem Cell? History of the Technology Corporate Development of Stem Cell Technologies When Will There Be Payoff? Stem Cell Background Regenerative Biology Challenges in Stem Cell Research Technical Challenges in Stem Cell Research Comparisons of Embryonic and Adult Stem Cells Adult Stem Cells NIH Funding for Stem Cell Research Chapter Two: Demographics and Disease Modalities
Potential Disease Modalities Summary of Important Similarities and Differences Between Adult and Embryonic Stem Cells Actual and Potential Uses of Human Adult Stem Cells Chapter Three: Stem Cell Products In Research And Development The Potential for Stem Cell Products Areas of Product Development Neural, Brain, and Spinal Stem Cell Applications Liver Stem Cell Applications Pancreas Stem Cell Applications Cardiac Stem Cell Applications Renal Stem Cell Applications Blood Stem Cell Applications Retinal Stem Cell Applications Diabetes—Stem Cell Applications Orthopedics—Stem Cell Applications Other Stem Cell Applications Indications Chapter Four: Stem Cell Companies
Introduction Select Stem Cell Company Profiles Chapter Five: Academic Organizations In Stem Cell Research Activities
Introduction Highlights of Recent Academic Research Activities Academic and Government Organizations Listed by Area of Activity Literature Review of Academic and Non-Commercial Organizations Involved with Stem Cells Chapter Six: Stem Cell Research Suppliers and Enabling Technologies
Introduction Stem Cell Supply Research Activity Effectiveness of Research Products Challenges to the Supply Industry Activities of Suppliers in the Field Media Development Support for Stem Cell Research Acquisition Activity Established Suppliers Companies on the NIH Stem Cell Registry Concerns about Competence of Approved Cell Lines Organization Profiles: Organizations with NIH-Listed Stem Cell Lines Stem Cell Products Background Chapter Seven: Legislative, Social, and Political Issues
Concerns Regarding Origins of Stem Cells Potential for Irresponsible Research Impact of Restrictions on Embryonic Stem Cells Alternative Sources of Stem Cells Events in Stem Cell Legislation and Ethics International Stem Cell Rules and Legislation Chapter Eight: Strategic Issues
The Investment Climate US Regulatory Issues Regulatory Issues in Europe and Japan Reimbursement Enabling Technologies Appendix A: Stem Cells: A Primer
National Institutes of Health Appendix B: Stem Cell Researchers and Links Coalition for the Advancement of Medical Research Appendix C: Stem Cell Glossary Key Terms in Stem Cell Technology General Glossary List of Exhibits Table 1-1: Timeline of Human Embryonic Stem Cell Research Table 2-1: Diseases for Which Unrelated Marrow Donor Transplants Have Been Performed Table 4-1: Companies, Contact Details, and Descriptions Table 4-2: Cord blood and Therapeutic Stem Cell Services Companies Table 5-1. Stem Cells Academic/Government Organizations Table 6-1: Companies and Research Laboratories with Stem Cell Lines Table 6-2. Select Organizations Providing Cell Lines Table 6-3. Cell Culture Systems: Media, Sera and Cell Growth Systems for Stem Cell Reagents: Stem Cell Factors/Cytokines, Antibodies, Conjugates, Growth Factors, Kits, Services Table 7-1: Events in Stem Cell Policy and Ethics Table 7-2: Results of Poll asking "Do You Support Federal Funding for Stem-Cell Research?" Table 7-3: Organizations Involved in Bioethics Table 7-4: Summary of September 1999 NBAC Recommendations on Stem Cell Research Table B-1: Academic and Government Laboratories Involved in Stem Cell Research Sorted by Organization Table B-2: Researchers at Commercial Stem Cell Organizations Contributing to 7/01 NIH Report Table B-3: Stem Cell Web Links AbstractIn the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem cell therapies products is very large. This report aims to identify those technologies and opportunities in the United States with the greatest future opportunities, the opportunities to develop enabling technologies in the field, and the organizations and laboratories performing current research. In addition, a section is included that covers the legislative, political and social issues surrounding stem cell technology and research. These issues are impacting the development of the technology.Objectives This report is a convenient and comprehensive report on stem cells and the technologies being development. Objectives of the report include the following:
Audience This report is designed to be used primarily by executives, investors, venture capitalists, and business development managers and analysts involved in the pharmaceutical or biotechnology areas that may have an interest in stem cell technology. Companies and organizations seeking to identify partners with complementary technologies may also find this report valuable. Stem cell research and the accompanying enabling technologies have virtually exploded since embryonic stem cells were first isolated in 1998. Many of the enabling and complementary technologies impacting stem cells are only now catching up to the rate of research. As such, there is a section on companies supplying the research, including those with cell lines, cell and tissue culture media, and reagents. The report includes detailed profiles and information on:
Because of the early stages of product development, near-term estimates on products currently in development would be pure speculation. The vast majority of products to be discussed have yet to be developed, and we expect any projections made here would be shown to be inaccurate within 5 years.
|
|
|||
|
About MarketResearch.com
|
||||